---
title: "NovAccess Global Inc. (XSNX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/XSNX.US.md"
symbol: "XSNX.US"
name: "NovAccess Global Inc."
industry: "Biotechnology"
---

# NovAccess Global Inc. (XSNX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.novaccessglobal.com](https://www.novaccessglobal.com) |

## Company Profile

NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorpora...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.01 | 76/605 | - | - | - |
| PB | 0.00 | 457/605 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/XSNX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/XSNX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/XSNX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.